Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other hematologic neoplasm 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1

Interventions

Cyclophosphamide 9 Radiotherapy 8 Temozolomide 6 Magnetic Resonance Spectroscopy 6 Filgrastim 6 Doxorubicin 6 pazopanib 5 Gemcitabine 5 pembrolizumab 4 Vincristine 4 Radiation 4 Etoposide 4 Docetaxel 4 Carboplatin 4 Biopsy 4 Trabectedin 3 Taxes 3 Specimen Handling 3 Paclitaxel 3 Nivolumab 3 Irinotecan 3 Drug Therapy 3 olaparib 2 niraparib 2 liposomal doxorubicin 2 fludarabine phosphate 2 fludarabine 2 brigimadlin 2 Trastuzumab 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × ficlatuzumab × Sarcoma × Clear all

NCT01189513 2012-02-20

SCH-900105 in Recurrent Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡